January 2019
Volume 32, No. 1 |
|
|
|
|
|
| COVER STORY |
Rita C. Peters
Bio/pharma companies are successfully launching novel therapies; however, the industry still needs to work on manufacturing innovation.
read more
| SPECIAL REPORT: EMPLOYMENT SURVEY |
Rita C. Peters
Compensation and professional challenges are key pieces to solving the biopharma employee satisfaction puzzle.
read more
| UPSTREAM: CELL CULTURE |
Feliza Mirasol
Automation in cell-line development and cell culture is leading to more consistent quality while improving efficiency, and, ultimately, speed to market.
read more
|
|
|
| BioPharm International January Issue
|
advertisement
 |
|
| DOWNSTREAM: SEPARATION AND PURIFICATION |
Cynthia A. Challener
New ligands are being developed to meet the separation and purification needs of next-gen biologics.
read more
| PEER-REVIEWED |
Torsten Bisschop, Karen Chan, and Herb Lutz
This article highlights a case study in which a static cleaning methodology was applied for SPTFF.
read more
|
|
|
advertisement
 |
|
| FACILITY DESIGN |
Jeff Odum
For rapid scale-up, facility design must better integrate product development and manufacturing lifecycle activities.
read more
| STABILITY TESTING |
Anurag S. Rathore, Rohit Bansal
Kinetic models can be used to study aggregation and fragmentation to help ensure stability.
read more
|
|
|
| FROM THE EDITOR |
Rita C. Peters
Pricing pressures, investment volatility, and government dysfunction greet Biopharma in 2019.
read more
| REGULATORY BEAT |
Jill Wechsler
FDA plans to support initiatives to ensure that all medicines are safe, effective, and of high quality.
read more
| PERSPECTIVES ON OUTSOURCING |
Ronald A. Rader and Eric S. Langer
Outsourcing of manufacturing activities is expected to increase in 2019.
read more
| ASK THE EXPERT |
Siegfried Schmitt
Understanding the differences in inspection processes is the key to successful global expansion.
read more
|
|
|
| EVENTS |
March 11–13, 2019
March 17–21, 2019
March 18–21, 2019
more events
|
|
|
|
|
